Atossa Therapeutics
ATOS
#9966
Rank
โ‚น3.16 B
Marketcap
โ‚น367.25
Share price
-15.98%
Change (1 day)
442.36%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2025 (TTM): -โ‚น21.52

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น22.67. In 2024 the company made an earnings per share (EPS) of -โ‚น18.14 an increase over its 2023 EPS that were of -โ‚น21.76.

EPS history for Atossa Therapeutics from 2010 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น21.5218.67%
2024-โ‚น18.14-16.67%
2023-โ‚น21.7614.29%
2022-โ‚น19.0416.67%
2021-โ‚น16.32-90.86%
2020-โ‚น178.64-2.96%
2019-โ‚น184.08-63.09%
2018-โ‚น498.73-49.63%
2017-โ‚น990.21-57.87%
2016-โ‚น2,350-74.01%
2015-โ‚น9,042-9.18%
2014-โ‚น9,956-12.86%
2013-โ‚น11,42570.73%
2012-โ‚น6,69234.08%
2011-โ‚น4,991263.47%
2010-โ‚น1,373

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น1,010-4,554.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น783.46-3,556.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น929.45-4,200.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น79.80 252.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-โ‚น19.04-16.00%๐Ÿ‡บ๐Ÿ‡ธ USA